Literature DB >> 7802118

Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease.

R Migliorelli1, A Tesón, L Sabe, M Petracchi, R Leiguarda, S E Starkstein.   

Abstract

OBJECTIVE: The purpose of this study was to examine the prevalence, risk factors, and correlates of depression among patients with Alzheimer's disease.
METHOD: A consecutive series of 103 patients with probable Alzheimer's disease were examined with a structured psychiatric interview and were assessed for the presence of cognitive impairments, deficits in activities of daily living, social functioning, and anosognosia.
RESULTS: Fifty-one percent of the patients had depression (28% had dysthymia and 23% major depression). Women had a significantly higher prevalence of both major depression and dysthymia than men. Depressed and nondepressed patients had a similar frequency of family and personal histories of depression, a similar frequency of personality disorders before the onset of depression, and no significant differences in cognitive deficits and impairment in activities of daily living. Dysthymia usually started after the onset of dementia and was significantly more prevalent in the early stages of dementia; patients with dysthymia had a significantly better awareness of intellectual deficits than patients with major or no depression. On the other hand, patients with major depression had an earlier onset of depression (half of them before the onset of dementia), and the prevalence of major depression was similar across the different stages of the illness.
CONCLUSIONS: This study demonstrates a high prevalence of dysthymia and major depression among patients with probable Alzheimer's disease. While dysthymia may be an emotional reaction to the progressive cognitive decline, major depression may be related to biological factors.

Entities:  

Mesh:

Year:  1995        PMID: 7802118     DOI: 10.1176/ajp.152.1.37

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

1.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

2.  Persistent depressive symptoms and cognitive function in late midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; Tasnime N Akbaraly; Michael Marmot; Maria Melchior; Joël Ankri; Séverine Sabia; Jane E Ferrie
Journal:  J Clin Psychiatry       Date:  2010-06-01       Impact factor: 4.384

3.  Galantamine in the treatment of minor depression with mild to moderate Alzheimer's dementia in an elderly woman.

Authors:  Kannayiram Alagiakrishnan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease.

Authors:  Eric Salmon; Daniela Perani; Karl Herholz; Patricia Marique; Elke Kalbe; Vjera Holthoff; Xavier Delbeuck; Bettina Beuthien-Baumann; Oriana Pelati; Solange Lespagnard; Fabienne Collette; Gaëtan Garraux
Journal:  Hum Brain Mapp       Date:  2006-07       Impact factor: 5.038

5.  A diagnostic formulation for anosognosia in Alzheimer's disease.

Authors:  S E Starkstein; R Jorge; R Mizrahi; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

6.  Depression rating scales in Parkinson's disease: critique and recommendations.

Authors:  Anette Schrag; Paolo Barone; Richard G Brown; Albert F G Leentjens; William M McDonald; Sergio Starkstein; Daniel Weintraub; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2007-06-15       Impact factor: 10.338

7.  Increasing Memory Self-Efficacy and Strategy Use in Hispanic Elders.

Authors:  Graham J McDougall
Journal:  Clin Gerontol       Date:  1998       Impact factor: 2.619

Review 8.  Shared cognitive and behavioral impairments in epilepsy and Alzheimer's disease and potential underlying mechanisms.

Authors:  Jeannie Chin; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-13       Impact factor: 2.937

Review 9.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

10.  Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Sarah Jane Banks; Sandra Weintraub
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.